“The Effectiveness of Semaglutida in Preventing Cardiovascular Risks Associated With Obesity and Diabetes”. Revista Eletrônica Acervo Médico, vol. 25, Oct. 2025, p. e21868, https://doi.org/10.25248/reamed.e21868.2025.